Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Law Bytes
Episode 65: My Ian Kerr Memorial Lecture – Privacy and Zambonis in the Age of COVID-19
Search Results placeholder
Recent Posts
“Get Money from Web Giants” Grows: Canadian Heritage Minister Guilbeault Says Government Working on a New Data Tax 
An Anti-Digital Agenda: Forget the Digital Policy Reboot, the Government Just Hit Delete Instead 
“Get Money From Web Giants”: Why Canadian Heritage Minister Steven Guilbeault’s Top Legislative Priority is Risky Business 
Why It’s Time to Reboot Canada’s Failed Digital Agenda 
Weakening Net Neutrality: How the Government’s Internet Regulation Plan Abandons the Principle of Equal Treatment of Content Online
